Supplemental material
Gut Microbes
Volume 16, 2024 - Issue 1
Open access
1,199
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology
Lise Hunaulta Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, France;b Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France;c Collège doctoral, Sorbonne Université, Paris, FranceView further author information
, Emile Auriad Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Université Paris-Cité, UMR-CNRS 6047, Paris, FranceView further author information
, Patrick Englande Department of Structural Biology and Chemistry, Institut Pasteur, Université Paris Cité, CNRS UMR3528, Plateforme de Biophysique Moléculaire, Paris, FranceView further author information
, Julien Deschampsf Institut Micalis, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, FranceView further author information
, Romain Briandetf Institut Micalis, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, FranceView further author information
, Vanessa Kremerb Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, France;g Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, Inserm, Châtenay-Malabry, FranceView further author information
, Bruno Iannascolib Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, FranceView further author information
, Léo Vidal-Maisona Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, FranceView further author information
, Chunguang Guoh Regeneron Pharmaceuticals, Tarrytown, NY, USAView further author information
, Lynn Macdonaldh Regeneron Pharmaceuticals, Tarrytown, NY, USAView further author information
, Séverine Péchinéi Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Institut MICALIS (UMR 1319 Université Paris-Saclay, INRAE, AgroParisTech), Orsay, FranceView further author information
, Cécile Denève-Larrazeti Equipe Bactéries Pathogènes et Santé, Faculté de Pharmacie, Institut MICALIS (UMR 1319 Université Paris-Saclay, INRAE, AgroParisTech), Orsay, FranceView further author information
, Bruno Dupuyd Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Université Paris-Cité, UMR-CNRS 6047, Paris, FranceView further author information
, Guy Gorochova Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, FranceCorrespondence[email protected]
View further author information
, View further author information
Pierre Bruhnsb Antibodies in Therapy and Pathology, Institut Pasteur, Université Paris-Cité, Inserm UMR1222, Paris, FranceCorrespondence[email protected]
[email protected]
https://orcid.org/0000-0002-4709-8936View further author information
& [email protected]
https://orcid.org/0000-0002-4709-8936View further author information
Delphine Sterlina Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Inserm, CNRS, Paris, FranceCorrespondence[email protected]
View further author information
show allView further author information
Article: 2301147
|
Received 11 Sep 2023, Accepted 28 Dec 2023, Published online: 30 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.